Adaptive Biotechnologies Corporation (ADPT) vs Dianthus Therapeutics, Inc. (DNTH)
A side-by-side comparison of Adaptive Biotechnologies Corporation and Dianthus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$28.20HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
DNTH
Dianthus Therapeutics, Inc.
$84.49HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — ADPT vs DNTH
growth of $100 · dividends reinvested · last 7yADPT -26.0% (-4.2%/yr)DNTH -62.7% (-13.1%/yr)ADPT compounded faster over this window
ADPT DNTH
ADPT vs DNTH: by the numbers
- •DNTH is the larger company ($4.73B vs $4.51B market cap).
- •Both run net losses; ADPT's is the smaller (-20.73% vs -1570.85% net margin).
Metrics side by side
Valuation
| Metric | ADPT | DNTH |
|---|---|---|
| P/S ratio | 14.65 | 2482.09 |
| P/B ratio | 31.58 | 4.03 |
Profitability
| Metric | ADPT | DNTH |
|---|---|---|
| Gross margin | 75.44% | 96.01% |
| Operating margin | -20.62% | -8739.34% |
| Net margin | -20.73% | -1570.85% |
| ROE | -44.68% | -2.55% |
| ROIC | -6.67% | -18.48% |
Growth (annualized)
| Metric | ADPT | DNTH |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | N/A |
| Total return CAGR (5Y) | -1.77% | -5.50% |
Frequently asked
- How have ADPT and DNTH total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and DNTH delivered -5.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Adaptive Biotechnologies ROEDianthus Therapeutics ROEAdaptive Biotechnologies operating marginDianthus Therapeutics operating marginAdaptive Biotechnologies revenue growthDianthus Therapeutics revenue growthAdaptive Biotechnologies free cash flowDianthus Therapeutics free cash flow
Adaptive Biotechnologies & Dianthus Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.